Witnessing the stock’s movement on the chart, on Thursday, Relay Therapeutics Inc (NASDAQ: RLAY) set off with pace as it heaved 4.54% to $6.45, before settling in for the price of $6.17 at the close. Taking a more long-term approach, RLAY posted a 52-week range of $1.77-$7.64.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -23.05%. Meanwhile, its Annual Earning per share during the time was -23.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 26.34%. This publicly-traded company’s shares outstanding now amounts to $172.63 million, simultaneously with a float of $131.71 million. The organization now has a market capitalization sitting at $1.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $5.74, while the 200-day Moving Average is $3.95.
Relay Therapeutics Inc (RLAY) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Relay Therapeutics Inc’s current insider ownership accounts for 24.42%, in contrast to 74.80% institutional ownership. According to the most recent insider trade that took place on Nov 03 ’25, this organization’s President and CEO sold 62,073 shares at the rate of 7.00, making the entire transaction reach 434,511 in total value, affecting insider ownership by 703,215. Preceding that transaction, on Oct 29 ’25, Company’s insider sold 21,394 for 7.50, making the whole transaction’s value amount to 160,455. This particular insider is now the holder of 337,469 in total.
Relay Therapeutics Inc (RLAY) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year. Relay Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 26.34% and is forecasted to reach -1.71 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.08% through the next 5 years, which can be compared against the -23.05% growth it accomplished over the previous five years trading on the market.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Let’s observe the current performance indicators for Relay Therapeutics Inc (RLAY). It’s Quick Ratio in the last reported quarter now stands at 19.14. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 133.72.
In the same vein, RLAY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.75, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.71 at the market close of one year from today.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Going through the that latest performance of [Relay Therapeutics Inc, RLAY]. Its last 5-days volume of 3.03 million indicated improvement to the volume of 2.15 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 25.52% While, its Average True Range was 48.08.
Raw Stochastic average of Relay Therapeutics Inc (RLAY) in the period of the previous 100 days is set at 74.21%, which indicates a major rise in contrast to 29.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.39 that was higher than 0.29 volatility it exhibited in the past 100-days period.
